Are Elderly Patients at Increased Risk of Complications Following Pacemaker Implantation? A Meta-Analysis of Randomized Trials

Background:  Patients over the age of 75 represent more than half the recipients of permanent pacemakers. It is not known if they have a different risk of complications than younger patients. Methods:  Patient‐level data were pooled from the CTOPP, UKPACE, and Danish pacing trials. These three rando...

Full description

Saved in:
Bibliographic Details
Published in:Pacing and clinical electrophysiology Vol. 35; no. 2; pp. 131 - 134
Main Authors: ARMAGANIJAN, LUCIANA V., TOFF, WILLIAM D., NIELSEN, JENS C., ANDERSEN, HENNING R., CONNOLLY, STUART J., ELLENBOGEN, KENNETH A., HEALEY, JEFF S.
Format: Journal Article
Language:English
Published: Malden, USA Blackwell Publishing Inc 01-02-2012
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background:  Patients over the age of 75 represent more than half the recipients of permanent pacemakers. It is not known if they have a different risk of complications than younger patients. Methods:  Patient‐level data were pooled from the CTOPP, UKPACE, and Danish pacing trials. These three randomized trials of pacing mode systematically captured early and late complications following pacemaker insertion. Early postimplant complications included lead dislodgement or loss of capture, cardiac perforation, pneumothorax, hematoma, infection, and death. Lead fracture was considered a late complication. Results:  A total of 4,814 patients were included in this analysis, with an average follow‐up of 5.1 years. The average age was 76 years and 43% were female. Any early complication occurred in 5.1% of patients ≥75 years of age compared to 3.4% of patients aged <75 years (P = 0.006). This was driven by an increased risk of pneumothorax (1.6% vs 0.8%, P = 0.07) and both atrial and ventricular lead dislodgement/loss of capture (2.0% vs 1.1%, P = 0.07). Early complications were higher in patients receiving atrial‐based pacemakers in both age groups (<75 years: 4.6% vs 2.4%; ≥75 years: 6.6% vs 3.7%); however, the relative risk was not influenced by age group. Older patients had a lower risk of lead fracture (3.6% vs 2.7%, P = 0.08). Conclusion:  Elderly patients (≥75 years of age) are at increased risk of early postimplant complications but are at lower risk for lead fracture. PACE 2012; 35:131–134)
Bibliography:istex:EE5A024A7718C7B155CA5869E4F342BFFE2BD18C
ArticleID:PACE3240
ark:/67375/WNG-QWZ3B0MM-X
Disclosures: Drs. L.V. Armaganijan, J.C. Nielsen, H.R. Andersen, and W.D. Toff have no disclosures. Dr. J.S. Healey receives research grant from Boston Scientific. Dr. K.A. Ellenbogen receives a research grant from Medtronic, Boston Scientific, Biosense Webster, and Sanofi Aventis; consulting and honoraria from Medtronic, Boston Scientific, St. Jude Medical, and Biotronik; and fellowship support from Medtronic, Boston Scientific, and Biosense Webster.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0147-8389
1540-8159
DOI:10.1111/j.1540-8159.2011.03240.x